PERCEPTIVE ADVISORS LLC

Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol: IKT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned: 12,816,643 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

17 Feb 2026 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,816,643 shares of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT). This represents 10% ownership of the company. This is the first filing by PERCEPTIVE ADVISORS LLC disclosing ownership of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Perceptive Advisors LLC	10%		$25,633,286	12,816,643			$2.00	13G/A	31 Dec 2025	17 Feb 2026, 16:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.2%	0%	$11,114,214	5,421,568	0		$2.05	Q4 2025
30 Sep 2025	0.26%	-0%	$8,782,940	5,421,568	-10,725	-0.2%	$1.62	Q3 2025
30 Jun 2025	0.4%	-0.04%	$10,592,971	5,432,293	-492,707	-8.3%	$1.95	Q2 2025
31 Mar 2025	0.46%	0%	$12,975,750	5,925,000	0		$2.19	Q1 2025
31 Dec 2024	0.54%	+0.54%	$19,256,250	5,925,000	+5,925,000	NEW	$3.25	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.